80 related articles for article (PubMed ID: 20687538)
21. Modulation of P-glycoprotein-mediated multidrug resistance in K562 leukemic cells by indole-3-carbinol.
Arora A; Seth K; Kalra N; Shukla Y
Toxicol Appl Pharmacol; 2005 Feb; 202(3):237-43. PubMed ID: 15667829
[TBL] [Abstract][Full Text] [Related]
22. Persistent reversal of P-glycoprotein-mediated daunorubicin resistance by tetrandrine in multidrug-resistant human T lymphoblastoid leukemia MOLT-4 cells.
Liu ZL; Hirano T; Tanaka S; Onda K; Oka K
J Pharm Pharmacol; 2003 Nov; 55(11):1531-7. PubMed ID: 14713364
[TBL] [Abstract][Full Text] [Related]
23. A mechanistic study of enhanced doxorubicin uptake and retention in multidrug resistant breast cancer cells using a polymer-lipid hybrid nanoparticle system.
Wong HL; Bendayan R; Rauth AM; Xue HY; Babakhanian K; Wu XY
J Pharmacol Exp Ther; 2006 Jun; 317(3):1372-81. PubMed ID: 16547167
[TBL] [Abstract][Full Text] [Related]
24. Reversal of P-gp mediated multidrug resistance in-vitro and in-vivo by FG020318.
Chen LM; Liang YJ; Ruan JW; Ding Y; Wang XW; Shi Z; Gu LQ; Yang XP; Fu LW
J Pharm Pharmacol; 2004 Aug; 56(8):1061-6. PubMed ID: 15285852
[TBL] [Abstract][Full Text] [Related]
25. Regulation of adipocyte differentiation by PEGylated all-trans retinoic acid: reduced cytotoxicity and attenuated lipid accumulation.
Moon HS; Guo DD; Song HH; Kim IY; Jiang HL; Kim YK; Chung CS; Choi YJ; Lee HK; Cho CS
J Nutr Biochem; 2007 May; 18(5):322-31. PubMed ID: 16963253
[TBL] [Abstract][Full Text] [Related]
26. CJY, an isoflavone, reverses P-glycoprotein-mediated multidrug-resistance in doxorubicin-resistant human myelogenous leukaemia (K562/DOX) cells.
Ji BS; He L
J Pharm Pharmacol; 2007 Jul; 59(7):1011-5. PubMed ID: 17637197
[TBL] [Abstract][Full Text] [Related]
27. Retinol inhibits the growth of all-trans-retinoic acid-sensitive and all-trans-retinoic acid-resistant colon cancer cells through a retinoic acid receptor-independent mechanism.
Park EY; Dillard A; Williams EA; Wilder ET; Pepper MR; Lane MA
Cancer Res; 2005 Nov; 65(21):9923-33. PubMed ID: 16267017
[TBL] [Abstract][Full Text] [Related]
28. Modulation of multidrug resistance by andrographolid in a HCT-8/5-FU multidrug-resistant colorectal cancer cell line.
Han Y; Bu LM; Ji X; Liu CY; Wang ZH
Chin J Dig Dis; 2005; 6(2):82-6. PubMed ID: 15904426
[TBL] [Abstract][Full Text] [Related]
29. Antitumor activity of terpenoids against classical and atypical multidrug resistant cancer cells.
Lage H; Duarte N; Coburger C; Hilgeroth A; Ferreira MJ
Phytomedicine; 2010 May; 17(6):441-8. PubMed ID: 19682879
[TBL] [Abstract][Full Text] [Related]
30. In vitro cytotoxic activity of cationic paclitaxel nanoparticles on MDR-3T3 cells.
Niu G; Castro CH; Nguyen N; Sullivan SM; Hughes JA
J Drug Target; 2010 Jul; 18(6):468-76. PubMed ID: 20059301
[TBL] [Abstract][Full Text] [Related]
31. Hyaluronic acid modified mesoporous silica nanoparticles for targeted drug delivery to CD44-overexpressing cancer cells.
Yu M; Jambhrunkar S; Thorn P; Chen J; Gu W; Yu C
Nanoscale; 2013 Jan; 5(1):178-83. PubMed ID: 23076766
[TBL] [Abstract][Full Text] [Related]
32. Antimultidrug-resistant effect and mechanism of a novel CA-4 analogue MZ3 on leukemia cells.
Xu D; Fang L; Zhu Q; Hu Y; He Q; Yang B
Pharmazie; 2008 Jul; 63(7):528-33. PubMed ID: 18717489
[TBL] [Abstract][Full Text] [Related]
33. Modulation of P-glycoprotein function and reversal of multidrug resistance by (-)-epigallocatechin gallate in human cancer cells.
Qian F; Wei D; Zhang Q; Yang S
Biomed Pharmacother; 2005 Apr; 59(3):64-9. PubMed ID: 15795098
[TBL] [Abstract][Full Text] [Related]
34. Berberine modulates expression of mdr1 gene product and the responses of digestive track cancer cells to Paclitaxel.
Lin HL; Liu TY; Wu CW; Chi CW
Br J Cancer; 1999 Oct; 81(3):416-22. PubMed ID: 10507765
[TBL] [Abstract][Full Text] [Related]
35. The cancer stem cell selective inhibitor salinomycin is a p-glycoprotein inhibitor.
Riccioni R; Dupuis ML; Bernabei M; Petrucci E; Pasquini L; Mariani G; Cianfriglia M; Testa U
Blood Cells Mol Dis; 2010 Jun; 45(1):86-92. PubMed ID: 20444629
[TBL] [Abstract][Full Text] [Related]
36. P-glycoprotein expression and chemosensitivity in highly purified fresh human gastrointestinal cancer cells.
Hotta T; Tanimura H; Tsunoda T; Iwahashi M; Tani M; Noguchi K; Mizobata S; Arii K; Terasawa H; Nakamori M; Yamaue H
Hepatogastroenterology; 1999; 46(25):316-21. PubMed ID: 10228815
[TBL] [Abstract][Full Text] [Related]
37. P-glycoprotein, expressed in multidrug resistant cells, is not responsible for alterations in membrane fluidity or membrane potential.
Alemán C; Annereau JP; Liang XJ; Cardarelli CO; Taylor B; Yin JJ; Aszalos A; Gottesman MM
Cancer Res; 2003 Jun; 63(12):3084-91. PubMed ID: 12810633
[TBL] [Abstract][Full Text] [Related]
38. Connexin 32 potentiates vinblastine-induced cytotoxicity in renal cell carcinoma cells.
Sato H; Senba H; Virgona N; Fukumoto K; Ishida T; Hagiwara H; Negishi E; Ueno K; Yamasaki H; Yano T
Mol Carcinog; 2007 Mar; 46(3):215-24. PubMed ID: 17186540
[TBL] [Abstract][Full Text] [Related]
39. Cationic Conjugated Polymer/Hyaluronan-Doxorubicin Complex for Sensitive Fluorescence Detection of Hyaluronidase and Tumor-Targeting Drug Delivery and Imaging.
Huang Y; Song C; Li H; Zhang R; Jiang R; Liu X; Zhang G; Fan Q; Wang L; Huang W
ACS Appl Mater Interfaces; 2015 Sep; 7(38):21529-37. PubMed ID: 26331442
[TBL] [Abstract][Full Text] [Related]
40. Evaluation of hyaluronic acid-protein conjugates for polymer masked-unmasked protein therapy.
Ferguson EL; Alshame AM; Thomas DW
Int J Pharm; 2010 Dec; 402(1-2):95-102. PubMed ID: 20888405
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
